{"address1": "234 Church Street", "address2": "Suite 1020", "city": "New Haven", "state": "CT", "zip": "06510", "country": "United States", "phone": "203 859 3820", "website": "https://www.rallybio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. It entered into a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases; and collaboration agreement with Johnson & Johnson to provide pregnant individuals therapeutic solutions at risk of fetal and neonatal alloimmune thrombocytopenia. The company was founded in 2018 and is headquartered in New Haven, Connecticut.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin W. MacKay Ph.D.", "age": 68, "title": "Co-Founder & Chairman", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 723350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Uden M.B, M.D.", "age": 66, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 723350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan I. Lieber M.B.A.", "age": 54, "title": "CFO & Treasurer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 667134, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven W. Ryder F.A.C.P, M.D.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 680219, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6545, "open": 0.7096, "dayLow": 0.6, "dayHigh": 0.71, "regularMarketPreviousClose": 0.6545, "regularMarketOpen": 0.7096, "regularMarketDayLow": 0.6, "regularMarketDayHigh": 0.71, "payoutRatio": 0.0, "beta": -1.448, "forwardPE": -0.48412699, "volume": 52126, "regularMarketVolume": 52126, "averageVolume": 56748, "averageVolume10days": 43490, "averageDailyVolume10Day": 43490, "bid": 0.4515, "ask": 0.784, "bidSize": 2, "askSize": 2, "marketCap": 25383320, "fiftyTwoWeekLow": 0.6, "fiftyTwoWeekHigh": 3.46, "priceToSalesTrailing12Months": 39.91088, "fiftyDayAverage": 0.75102, "twoHundredDayAverage": 1.041505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -39973656, "profitMargins": 0.0, "floatShares": 19732013, "sharesOutstanding": 41612000, "sharesShort": 337792, "sharesShortPriorMonth": 331091, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0081, "heldPercentInsiders": 0.04045, "heldPercentInstitutions": 0.77075, "shortRatio": 6.64, "shortPercentOfFloat": 0.0114, "impliedSharesOutstanding": 41612000, "bookValue": 1.485, "priceToBook": 0.4107744, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -57775000, "trailingEps": -1.33, "forwardEps": -1.26, "enterpriseToRevenue": -62.852, "enterpriseToEbitda": 0.7, "52WeekChange": -0.6347306, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.61, "targetHighPrice": 13.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.25, "targetMedianPrice": 7.5, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 65511000, "totalCashPerShare": 1.574, "ebitda": -57065000, "totalDebt": 154000, "quickRatio": 10.495, "currentRatio": 10.868, "totalRevenue": 636000, "debtToEquity": 0.25, "revenuePerShare": 0.015, "returnOnAssets": -0.38914, "returnOnEquity": -0.68846, "grossProfits": -38871000, "freeCashflow": -28049500, "operatingCashflow": -49282000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -305.47366, "financialCurrency": "USD", "symbol": "RLYB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -6.7990823, "regularMarketPrice": 0.61, "marketState": "PRE", "fiftyDayAverageChange": -0.14102, "fiftyDayAverageChangePercent": -0.18777129, "twoHundredDayAverageChange": -0.43150496, "twoHundredDayAverageChangePercent": -0.41430908, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-29", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627565400000, "regularMarketChange": -0.044499993, "regularMarketDayRange": "0.6 - 0.71", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 56748, "fiftyTwoWeekLowChange": 0.00999999, "fiftyTwoWeekLowChangePercent": 0.01666665, "fiftyTwoWeekRange": "0.6 - 3.46", "fiftyTwoWeekHighChange": -2.85, "fiftyTwoWeekHighChangePercent": -0.8236994, "fiftyTwoWeekChangePercent": -63.473057, "epsTrailingTwelveMonths": -1.33, "epsForward": -1.26, "epsCurrentYear": -1.17, "priceEpsCurrentYear": -0.52136755, "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NMS", "messageBoardId": "finmb_1673028342", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Rallybio Corporation", "longName": "Rallybio Corporation", "displayName": "Rallybio", "trailingPegRatio": null}